New collaborations pairing drug makers with insurers, health systems, patient groups and technology firms are reconfiguring drug R&D and commercialization. Shared data is shaping drug development and demonstrating health outcomes to create value for patients and industry.
PwC’s Pharmaceutical and life sciences works with you from strategy through execution. Discover other ways we’ll help you succeed in the New Health Economy.